Yasuhiro Kuroda

Yasuhiro Kuroda

Auto-generated profile, based on publicly available information

Yasuhiro Kuroda

Kagawa University Hospital Emergency, Disaster Critical Care Medicine Kagawa Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Brain and Development
Verified
Journal Article
Closed access
Hiromichi ItoHiromichi Ito
Hiromichi Ito
KMKenji Mori
Kenji Mori
MHMasafumi Harada
Masafumi Harada
MMMasako Minato
Masako Minato
ENEtsuo Naito
Etsuo Naito
SKShoji Kagami
Shoji Kagami

1 May 2019 in Shock
Verified
Journal Article
Open access
SYShota Yokoyama
Shota Yokoyama
THToru Hifumi
Toru Hifumi
KKKenya Kawakita
Kenya Kawakita
TTTakashi Tamiya
Takashi Tamiya
TMTetsuo Minamino
Tetsuo Minamino
YKYasuhiro Kuroda
Yasuhiro Kuroda
Introduction: Although oxygen administration is fundamental in the management of aneurysmal subarachnoid hemorrhage (SAH) patients in the acute stage, hyperoxia has harmful effects. The effects of hyperoxia on neurological outcomes in SAH patients are unclear. We aimed to examine the association of hyperoxia during the first 24 h in the intensive care unit (ICU) with unfavorable neurological outcomes in SAH patients. Methods: We retrospectively selected consecutive adult patients admitted to ICU for SAH between January 2009 and April 2018. We defined normoxia during the first 24 h in ICU as PaO2 of 60 mm Hg to 120 mm Hg, mild hyperoxia as PaO2 of 121 mm Hg to 200 mm Hg, moderate hyperoxia as PaO2 of 201 mm Hg to 300 mm Hg, and severe hyperoxia as PaO2 of >300 mm Hg. Univariate and multivariate analyses were performed to examine the association between hyperoxia during the first 24 h in ICU and unfavorable neurological outcomes (i.e., modified Rankin scale score of 3–6 at hospital discharge). Results: Among 196 SAH patients, 90 had unfavorable neurological outcomes. Hyperoxia was observed in 93.4% of patients. No significant association was observed between unfavorable neurological outcomes and hyperoxia in overall patients. However, we found that early hyperoxia in ICU was significantly associated with unfavorable neurological outcomes in SAH patients with Hunt and Kosnik (H&K) grades I to III (Relative risk, 1.84; 95% confidence interval, 1.10–2.94; P = 0.02). Conclusions: Early hyperoxia was not associated with unfavorable neurological outcomes in overall SAH patients, but it was associated with unfavorable neurological outcomes in those with H&K grades I to III.

1 May 2000 in Stem Cells
Verified
Journal Article
Open access
PDF file
SKSachiyo Kanamaru
Sachiyo Kanamaru
YKYoshifumi Kawano
Yoshifumi Kawano
TWTsutomu Watanabe
Tsutomu Watanabe
RNRyuji Nakagawa
Ryuji Nakagawa
HSHiroko Suzuya
Hiroko Suzuya
YTYoichi Takaue
Yoichi Takaue
Delayed platelet recovery is an inherent problem with cord blood cell transplantation (CBCT). To investigate this problem, the number of human megakaryocyte (MK) progenitor cells in cord blood (CB; n = 24) was measured and compared with that in G-CSF-mobilized peripheral blood stem cells (PBSC; n = 25). The median numbers of colony-forming units for MK (CFU-MK) that were detected by a serum-free assay system in CB and peripheral blood (PB) were 26 (range, 6-102)/10(5) nucleated cells (NC) and 37 (2-540)/10(5) mononuclear cells (MNC), respectively. The numbers of colony-forming units for granulocyte/macrophage (CFU-GM) were 88 (33-241)/10(5) NC in CB and 138 (6.3-1,250)/10(5) MNC in PB. The frequencies of CD34(+) cells in CB and PB were, respectively, 0.44% (0.10-1.07) and 0.98% (0.05-20.8). The numbers of CFU-MK in CB and PBSC were correlated with those of CD34(+) cells. The estimated number of infused CFU-MK in CBCT was 1/15 that of PBSC transplantation (PBSCT), based upon the above data and the widely used standard doses for both types of transplants. Further, the numbers of infused CFU-MK in patients who received allogeneic PBSCT at our institute were inversely correlated with the speed of platelet recovery. These data indicate that delayed platelet recovery after CBCT is simply due to the low number of CFU-MK contained in grafts.

1 January 2017 in Circulation Journal
Verified
Journal Article
Open access
RNRyuta Nakashima
Ryuta Nakashima
THToru Hifumi
Toru Hifumi
KKKenya Kawakita
Kenya Kawakita
TOTomoya Okazaki
Tomoya Okazaki
SESatoshi Egawa
Satoshi Egawa
YKYasuhiro Kuroda
Yasuhiro Kuroda
The discussion of neurocritical care management in post-cardiac arrest syndrome (PCAS) has generally focused on target values used for targeted temperature management (TTM). There has been less attention paid to target values for systemic and cerebral parameters to minimize secondary brain damage in PCAS. And the neurologic indications for TTM to produce a favorable neurologic outcome remain to be determined. Critical care management of PCAS patients is fundamental and essential for both cardiologists and general intensivists to improve neurologic outcome, because definitive therapy of PCAS includes both special management of the cause of cardiac arrest, such as coronary intervention to ischemic heart disease, and intensive management of the results of cardiac arrest, such as ventilation strategies to avoid brain ischemia. We reviewed the literature and the latest research about the following issues and propose practical care recommendations. Issues are (1) prediction of TTM candidate on admission, (2) cerebral blood flow and metabolism and target value of them, (3) seizure management using continuous electroencephalography, (4) target value of hemodynamic stabilization and its method, (5) management and analysis of respiration, (6) sedation and its monitoring, (7) shivering control and its monitoring, and (8) glucose management. We hope to establish standards of neurocritical care to optimize brain function and produce a favorable neurologic outcome.

1 February 2019 in Vaccine
Verified
Journal Article
Closed access
RFRagab M. Fereig
Ragab M. Fereig
HAHanan H. Abdelbaky
Hanan H. Abdelbaky
YKYasuhiro Kuroda
Yasuhiro Kuroda
YNYoshifumi Nishikawa
Yoshifumi Nishikawa

1 January 1995 in American Journal of Nephrology
Verified
Journal Article
Closed access
PDF file
KOKaname Okada
Kaname Okada
YOYasuhiro Okamoto
Yasuhiro Okamoto
SKShoji Kagami
Shoji Kagami
MFMamoru Funai
Mamoru Funai
YMYuji Morimoto
Yuji Morimoto
YKYasuhiro Kuroda
Yasuhiro Kuroda
Acute interstitial nephritis (AIN) and uveitis of unknown etiology developed in a 15-year-old girl. Symptoms and urinary abnormalities improved spontaneously but moderate renal dysfunction and anterior uveitis persisted. A repeat biopsy performed 2 years later showed focal tubulointerstitial changes, while bone marrow examination revealed granulomas. Simultaneously, antineutrophil cytoplasmic antibodies (ANCA) were detected, and decreases in T cell population and lymphocyte function were found. These immunological abnormalities normalized in parallel with clinical improvement with corticosteroid therapy, strongly suggesting that in some patients autoimmune disorders contribute to the pathogenesis of the disease.